About Sunovion
Sunovion is a company based in Marlborough (United States) founded in 1984 was acquired by Sumitomo Dainippon Pharma in August 2021.. Sunovion has completed 2 acquisitions, including Cynapsus Therapeutics and Elevation Pharmaceuticals. Sunovion offers products and services including Drug Pipeline and Cell and Gene Therapies.
- Headquarter Marlborough, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Sumitomo Pharma America, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
- Investors
-
Employee Count
Employee Count
-
Investments & Acquisitions
Cynapsus Therapeutics
& 1 more
-
Acquired by
Sumitomo Dainippon Pharma
(Aug 19, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Sunovion
Sunovion offers a comprehensive portfolio of products and services, including Drug Pipeline and Cell and Gene Therapies. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Advances drugs for oncology and rare diseases through clinical trials
Develops treatments for genetic and rare conditions
Unlock access to complete
Funding Insights of Sunovion
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Sunovion
Sunovion has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Sumitomo Dainippon Pharma. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Pharmaceuticals, food ingredients, additives, and veterinary products are manufactured.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Sunovion
Sunovion has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Cynapsus Therapeutics and Elevation Pharmaceuticals. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Developer of aerosol drug products for COPD patients
|
2007 | ||||
|
Treatments for CNS disorders, including Parkinson's OFF episodes, are developed.
|
2004 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Sunovion
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Sunovion Comparisons
Competitors of Sunovion
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Sunovion
Frequently Asked Questions about Sunovion
When was Sunovion founded?
Sunovion was founded in 1984.
Where is Sunovion located?
Sunovion is headquartered in Marlborough, United States. It is registered at Marlborough, Massachusetts, United States.
What does Sunovion do?
Sunovion engages in discovering, developing, and commercializing therapeutic products for patients suffering from central nervous system disorders, respiratory disorders and other illnesses. Products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Zetonna (ciclesonide) Nasal Aerosol, and Alvesco (ciclesonide) Inhalation Aerosol. Pipeline includes latuda for pediatric schizophrenia, SUN-101 for COPD, dasotraline for ADHD and binge eating disorder, SB-623 for chronic stroke, SEP-856 for schizophrenia, DSP-2230 for neuropathic pain, DSP-3748 for cognitive impairment associated with schizophrenia and WT-2725 for hematologic and solid cancer.
What products or services does Sunovion offer?
Sunovion offers Drug Pipeline and Cell and Gene Therapies.
How many acquisitions has Sunovion made?
Sunovion has made 2 acquisitions, including Cynapsus Therapeutics, and Elevation Pharmaceuticals.
Who are Sunovion's investors?
Sunovion has 1 investor. Key investors include Sumitomo Dainippon Pharma.